The company expects to reach ₹2,900 crore in revenue this fiscal year following revenue of ₹2,500-2,530 crore in 2026
The post Capacity scale-ups to drive Epigral's ₹5,000 crore target by FY31: CMD appeared first on Home Page.
The company expects to reach ₹2,900 crore in revenue this fiscal year following revenue of ₹2,500-2,530 crore in 2026
The post Capacity scale-ups to drive Epigral's ₹5,000 crore target by FY31: CMD appeared first on Home Page.